Form 4: Guardant Health Director Exercises RSUs and Sells Shares Under Pre-Arranged Plan

Guardant Health, Inc. Director Meghan V. Joyce acquired 6,674 shares through RSU vesting and subsequently sold 3,337 shares for $47.22 each, all under a Rule 10b5-1 trading plan.

Summary

• Meghan V. Joyce, a Director of Guardant Health, Inc. (GH), reported transactions involving the company's common stock.
• On June 12, 2025, Ms. Joyce acquired 6,674 shares of common stock at a price of $0, resulting from the vesting of Restricted Stock Units (RSUs).
• Following this acquisition, her direct beneficial ownership increased to 14,487 shares.
• On June 13, 2025, Ms. Joyce sold 3,337 shares of common stock at a price of $47.22 per share.
• After the sale, her direct beneficial ownership of common stock decreased to 11,150 shares.
• Both transactions were conducted pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, indicating they were pre-scheduled.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a director sold shares, the sale was pre-planned under a 10b5-1 plan and followed the vesting of RSUs, which is a routine compensation event. The RSU vesting itself is a positive sign of continued equity alignment.

Positives

• The acquisition of 6,674 shares through RSU vesting indicates continued equity participation and alignment of interests between the director and shareholders.
• The transactions were conducted under a Rule 10b5-1 plan, suggesting the sale was pre-scheduled and not based on new, non-public information.

Negatives

• The sale of 3,337 shares by a director could be perceived negatively by some investors, as it reduces their direct equity stake in the company.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider equity transactions for a director at Guardant Health, a company operating in the precision oncology and diagnostics industry. Such transactions are common for executives and directors managing their equity compensation and personal finances, and do not inherently reflect broader industry trends unless part of a widespread pattern across multiple companies.

Related Party Transactions

• The filing details transactions by Meghan V. Joyce, a Director of Guardant Health, Inc., which are considered related-party transactions as they involve an insider of the company.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be viewed as a slight reduction in insider confidence, though mitigated by the Rule 10b5-1 plan. The RSU vesting aligns the director's interests with long-term shareholder value.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, Insider Trading, Director Stock Sale, Restricted Stock Units, RSU Vesting, Rule 10b5-1, Equity Compensation, Stock Transaction